Literature DB >> 12218645

Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction.

B Borroni1, R Volpi, G Martini, R Del Bono, S Archetti, F Colciaghi, N Maalikjy Akkawi, M Di Luca, G Romanelli, L Caimi, A Padovani.   

Abstract

Clinical and epidemiologic studies demonstrate that vascular risk factors may be involved in Alzheimer disease (AD). To evaluate whether vascular abnormalities are an early feature of AD, several parameters of coagulation and fibrinolysis were assessed. Thirty patients with mild AD and 30 age-matched control subjects entered the study. All subjects performed a standardized clinical and laboratory protocol. Persons with vascular risk factors and systemic diseases were excluded. AD patients present significant increased levels of thrombomodulin (p < 0.0001) and sE-selectin (p < 0.03). In contrast, no difference was found between the two diagnostic groups in the levels of beta-thromboglobulin, prothrombin fragment 1+2, fibrinogen, and von Willebrand factor. No other association but diagnosis was found with thrombomodulin and sE-selectin. These findings suggest that endothelial dysfunction is an early event in AD patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218645     DOI: 10.1097/00002093-200207000-00004

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  5 in total

1.  Potential biomarkers for vascular damage in Alzheimer's disease: thrombomodulin and von Willebrand factor.

Authors:  B B Yavuz; D S Dede; B Yavuz; M Cankurtaran; M Halil; Z Ulger; E S Cankurtaran; K Aytemir; G Kabakci; I C Haznedaroglu; S Ariogul
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

2.  Endothelial Activation Is Associated With Cognitive Performance in Patients With Hypertension.

Authors:  Renske Uiterwijk; Marjolein Huijts; Julie Staals; Rob P W Rouhl; Peter W De Leeuw; Abraham A Kroon; Robert J Van Oostenbrugge
Journal:  Am J Hypertens       Date:  2015-08-12       Impact factor: 2.689

Review 3.  Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Authors:  Rory J Kelleher; Roy L Soiza
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

4.  Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.

Authors:  Josef Marksteiner; Douglas Imarhiagbe; Michaela Defrancesco; Eberhard A Deisenhammer; Georg Kemmler; Christian Humpel
Journal:  Exp Gerontol       Date:  2013-12-10       Impact factor: 4.032

Review 5.  Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.

Authors:  Ilaria Canobbio; Aisha Alsheikh Abubaker; Caterina Visconte; Mauro Torti; Giordano Pula
Journal:  Front Cell Neurosci       Date:  2015-03-03       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.